Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. by Krausz, Csilla Gabriella et al.
doi:10.1136/jmg.2008.059915 
 2009;46;21-31; originally published online 9 Sep 2008; J. Med. Genet.
  
Balercia, P Piomboni, E Nieschlag, G Forti, R McLachlan and C Tyler-Smith 
Oliva, I Aknin-Seifer, E Erdei, N Jorgensen, M Simoni, J L Ballescà, R Levy, G 
C Krausz, C Giachini, Y Xue, M K O’Bryan, J Gromoll, E Rajpert-de Meyts, R
  
 of Y-chromosomal background
the Y-chromosomal gr/gr deletion is independent 
Phenotypic variation within European carriers of
 http://jmg.bmj.com/cgi/content/full/46/1/21
Updated information and services can be found at: 
 These include:
Data supplement
 http://jmg.bmj.com/cgi/content/full/46/1/21/DC1
 "web only appendices"
 References
  
 http://jmg.bmj.com/cgi/content/full/46/1/21#BIBL
This article cites 28 articles, 14 of which can be accessed free at: 
Rapid responses
 http://jmg.bmj.com/cgi/eletter-submit/46/1/21
You can respond to this article at: 
 service
Email alerting
the top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at
Topic collections
 (4890 articles) Reproductive medicine 
  
Articles on similar topics can be found in the following collections 
 Notes   
 http://journals.bmj.com/cgi/reprintform
To order reprints of this article go to: 
 http://journals.bmj.com/subscriptions/
 go to: Journal of Medical GeneticsTo subscribe to 
 on 7 January 2009 jmg.bmj.comDownloaded from 
Phenotypic variation within European carriers of
the Y-chromosomal gr/gr deletion is independent of
Y-chromosomal background
C Krausz,1 C Giachini,1 Y Xue,2 M K O’Bryan,3 J Gromoll,4 E Rajpert-de Meyts,5 R Oliva,6
I Aknin-Seifer,7 E Erdei,8 N Jorgensen,5 M Simoni,4,9 J L Ballesca`,10 R Levy,11
G Balercia,12 P Piomboni,13 E Nieschlag,4 G Forti,1 R McLachlan,14,15 C Tyler-Smith2
c Supplementary tables and
figure are published online only
at http://jmg.bmj.com/content/
vol46/issue1
For numbered affiliations see
end of article
Correspondence to:
Dr Csilla Krausz, Andrology Unit,
Department of Clinical
Physiopathology, University of
Florence, Viale Pieraccini, 6
Florence 50139, Italy;
c.krausz@dfc.unifi.it
Received 21 April 2008
Revised 7 August 2008
Accepted 17 August 2008
Published Online First
8 September 2008
ABSTRACT
Background: Previous studies have compared sperm
phenotypes between men with partial deletions within the
AZFc region of the Y chromosome and non-carriers, with
variable results. In this study, a separate question was
investigated, the basis of the variation in sperm
phenotype within gr/gr deletion carriers, which ranges
from normozoospermia to azoospermia. Differences in the
genes removed by independent gr/gr deletions, the
occurrence of subsequent duplications or the presence of
linked modifying variants elsewhere on the chromosome
have been suggested as possible causal factors. This
study set out to test these possibilities in a large sample
of gr/gr deletion carriers with known phenotypes spanning
the complete range.
Results: In total, 169 men diagnosed with gr/gr deletions
from six centres in Europe and one in Australia were
studied. The DAZ and CDY1 copies retained, the presence
or absence of duplications and the Y-chromosomal
haplogroup were characterised. Although the study had
good power to detect factors that accounted for >5.5%
of the variation in sperm concentration, no such factor
was found. A negative effect of gr/gr deletions followed
by b2/b4 duplication was found within the normospermic
group, which remains to be further explored in a larger
study population. Finally, significant geographical differ-
ences in the frequency of different subtypes of gr/gr
deletions were found, which may have relevance for the
interpretation of case control studies dealing with
admixed populations.
Conclusions: The phenotypic variation of gr/gr carriers in
men of European origin is largely independent of the
Y-chromosomal background.
The long arm of the human Y chromosome hosts a
number of genes involved in spermatogenesis, and
several types of recurrent Yq deletions are firmly
associated with spermatogenic failure1–3 (fig 1).
Apart from the classic AZF deletions, new types of
Yq rearrangements have recently attracted the
attention of geneticists and andrologists.4 The
complex duplicated structure of the AZFc region
predisposes to a series of rearrangements mediated
by non-allelic homologous recombination, includ-
ing the formation of partial deletions, deletion/
duplications, and partial duplications.5–7 The most
clinically relevant mutation is termed the ‘‘gr/gr’’
deletion8 and removes half of the AZFc gene
content. This deletion is a significant risk factor
for spermatogenic failure in some populations but
apparently not in others.9 These contradictory
results are likely to derive from methodological
differences between studies and recruitment biases.
In only a minority of studies have the controls
been normozoospermic men; controls and patients
were not matched for ethnic background in highly
admixed populations from Paris,10 southern
France11 and Brazil12 used in some studies, and
the proportion of subjects with azoospermia or
oligozoospermia differed between studies.
Although the debate about the significance of
the gr/gr deletion as a risk factor for impaired
sperm production is ongoing and unresolved, and
was not further investigated here, there is a firm
consensus about the heterogeneous phenotype
associated with gr/gr deletions.10–16 Even in studies
in which gr/gr deletion is clearly shown as a risk
factor for impaired spermatogenesis, the sperm
phenotype ranges from azoospermia to normo-
zoospermia.9 This phenomenon is in sharp contrast
to the classic AZF deletion phenotypes, which are
invariably associated with impaired sperm produc-
tion. Given that the number of genes removed by
the gr/gr deletion is half that of the classic AZFc
deletion, it is not unexpected that the effect of the
deletion is milder and it is therefore a cofactor for
spermatogenic impairment with variable pene-
trance. Thus, it is also possible that other Y-linked
or non-Y genetic factors influence the pathogeni-
city of the deletion. The significance of the
presence of polymorphisms or mutations in the
autosomal homologue of the DAZ gene, DAZL17
has been examined in one study,14 but it was
concluded that the polymorphic Thr12Ala change
(T12A) was unlikely to contribute and no new
mutations in the entire coding region of the DAZL
gene were identified. No other autosomal factors
modulating the deletion phenotype have yet been
reported.
For Y-related factors, interpretation is compli-
cated by the lack of recombination in the male-
specific part of the chromosome, which results in
complete linkage between variants throughout
most of the chromosome. Their likely importance
is illustrated by certain Y haplogroups (Y chromo-
some backgrounds defined by Y chromosome
single-nucleotide polymorphisms (SNPs)), which
carry fixed gr/gr deletions but are nevertheless
present at high frequency in some populations,
indicating that compensatory mechanisms may
exist on these backgrounds.18–20 The specific genes
removed can vary between gr/gr deletions and this
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Figure 1 Schematic representation of the Y chromosome showing the structures, genes, sequence-tagged sites and rearrangements relevant to this
study. (A) Deletions of the AZFa, AZFb and AZFc regions result in spermatogenic failure. AZFb deletions (two subtypes) overlap with the AZFc region.
(B) The AZFc region presented in more detail showing the location of multicopy genes and transcription units in the reference sequence published by
Skaletsky et al.3 This region contains a number of repeated sequences with the same orientation (matching arrows) which through intrachromosomal
recombination may lead to deletions. (C) The clinically relevant ‘‘b2/b4’’ (top) and ‘‘gr/gr’’ deletions (remainder) are shown. Half of the AZFc gene
content is removed by gr/gr deletions, but these can vary in breakpoints (deletion subtypes I and or according to the presence of a b3/b4 inversion
(deletion subtypes III and IV). (D) gr/gr deletion of subtype I or II followed by b2/b4 duplication. cen, centromere; PAR, pseudoautosomal region; Yp,
short arm of the Y chromosome; Yq, long arm of the Y chromosome.
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has been suggested as the most direct modulating factor. The
DAZ and CDY1 copies, which lie within the deleted region, have
been examined as possible predictors for pathogenicity. The loss
of DAZ1/DAZ2 and CDY1a has been reported as more
deleterious than loss of DAZ3/DAZ4 and CDY1b.14 18 21
Concerning the DAZ gene copies, different members of the
DAZ gene family have different number of RNA recognition
motifs (RRMs) and DAZ repeats, which may confer different
functional activity on the four DAZ copies. However, it is also
known that both elements show interindividual variability,
which in theory might be linked to a particular Y lineage.
Similarly, the loss of CDY1a or CDY1b copies might reflect a
different Y structure. In fact, in the reference sequence, CDY1b
lies outside the region that is predicted to be deleted by gr/gr
recombination. This implies that the CDY1b loss may occur
only in Y chromosomes that carry an inversion polymorphism
in the AZFc region,11 or must arise independently. Such an
inversion polymorphism may affect the transcription of the
remaining AZFc genes or may be linked to other Y structural
variations. An alternative explanation for the gr/gr deletions
found in normospermic men could be that a compensatory
duplication, such as a gr/gr deletion followed by b2/b4
duplication, has restored normal gene number and function.
Furthermore, Y variants outside the AZFc region may influence
spermatogenesis and these will be associated with particular
haplogroups, so may be recognised indirectly using a phyloge-
netic analysis. A well-resolved Y chromosome tree of 311
haplogroups is now available,22 as well as extensive information
about the haplogroups present in different regions of the world
including Europe.23–25 Consequently, a small number of infor-
mative Y-SNPs can be tested to identify the most prevalent
haplogroups in Europe.
Most studies of gr/gr deletions have used sequence tag site
(STS) +/2 PCR analysis to identify the deletion and thus have
been unable to provide information about the type of missing
gene copies or about deletion/duplication events. For a fuller
understanding, a method such as combined analysis based on a
first step of STS +/2 screening, followed by a confirmatory
dosage analysis and gene copy characterisation of the samples
with suspected deletions, is needed and has been described by
Giachini et al.14
The aim of the present study was to determine whether any
of the suggested Y-related factors can account for the different
semen phenotypes found in gr/gr deletion carriers, rather than
to re-investigate possible differences between carriers and non-
carriers. For this purpose, we collected 169 DNA samples from
seven countries that were previously defined by STS +/2
analysis as gr/gr deleted men. All subjects were further
characterised by gene dosage analysis, gene copy type and Y
haplogroup, and these factors were related to spermatogenic
Figure 2 Schematic representation of
the multistep gr/gr deletion screening
procedure and categories of gr/gr
subtypes defined. (A) Gene dosage and
restriction fragment length polymorphism
analysis was used to distinguish between
‘‘simple’’ gr/gr deletions, false deletions
and deletion/duplications events and to
define the missing gene copies, ie gr/gr
deletion subtypes (examples of
electropherograms shown; see Methods
for further details). *STS, sequence
tagged site-based PCR method, according
to Repping et al.8 (B) Molecular
characterisation of the various gr/gr
rearrangement types. Gene dosage of
CDY1 and DAZ and the possible
combinations of missing DAZ (DAZ1/
DAZ2/DAZ3/DAZ4) and CDY1 (CDY1a/
CDY1b) copy types are shown for each
rearrangement. *In the AZFc region:
sY142, sY1258, sY1161, sY1197, sY1191,
sY1206, sY1201. 1Six cases showed a
combination of DAZ copies from each
DAZ duplex, possibly DAZ1/3 or DAZ3/4.
+, P positive; 2, negative; del, deletion;
dupl, duplication; ampl, amplification.
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phenotype to search for a genetic profile specific for spermato-
genic failure.
METHODS
Patients and controls were recruited according to local ethics
committee policy and all subjects signed an informed consent
form.
Subjects analysed
In total, 169 DNA samples were analysed for classic AZF
deletions and for partial AZFc region deletions in the participat-
ing laboratories from the following countries: Australia (n = 50),
Denmark (n = 25), France (n = 13), Germany (n = 35), Hungary
(n = 4), Italy (n = 24) and Spain (n = 18). All 169 samples
showed absence of amplification for sY1291 but presence of the
other specific AZFc markers (sY142, sY1258, sY1161, sY1197,
sY1191, sY1206 andsY1201; see GenBank for PCR primers)
indicating the presence of a gr/gr deletion. Some of the patients/
controls with gr/gr deletions (based on STS analysis) have been
included in previous publications.13–16
The composition of the study population (n = 169) was as
follows: 152 infertile and 17 fertile or normospermic men sent as
‘‘controls’’ (supplementary table 1). All subjects were deter-
mined to be of European ancestry, either on the basis of their
surname or on direct questioning during recruitment about the
origin of their parents. Of the 152 infertile patients, semen
parameters were available for 134. In an additional 7 patients,
only the semen phenotype (azoospermia, oligozoospermia) was
given by the laboratories, and for the remaining 11 patients the
only information given was that they were infertile. The group
of 141 patients with known semen phenotype comprised 27
azoospermic, 18 cryptozoospermic (,1 million spermatazoa/ml),
82 oligozoospermic and 14 asthenoteratozoospermic subjects.
The mean (SD) values of the three principal sperm parameters
in the infertile group for which semen parameters were
provided were as follows: sperm concentration: 6.9
(14.7)6106/ml (n = 134); total sperm count: 24.8 (60.6)6106
(n = 114); percentage progressive motility: 16.2 (16.8)%
(n = 122); percentage normal morphology: 8.9 (8.1)% (n = 82).
Motility and/or morphology were not determined in azoospermic
and severely oligozoospermic men (,16106 spermatozoa/ml).
The mean sperm concentrations are reported for each country in
supplementary table 2 (online).
Semen parameters were available for all 17 controls (except two
(D255; B11) for whom morphology was not provided and one
(D255) for whom motility was not provided). The control
population consisted of 10 subjects presenting all the three major
sperm parameters (concentration, motility and morphology)
above the normal range;26 and 7 subjects presenting normal sperm
concentration but with motility and morphology below the
normal range. The mean (SD) values of the sperm parameters in
the control group were: sperm concentration: 76.8 (44.9)6106/ml
(n = 17); total sperm count: 328.4 (396.7)6106 (n = 13); percen-
tage progressive motility: 49.2 (13.3) (n = 16); percentage normal
morphology: 20.8 (11.8) (n = 15).
The 169 samples were analysed further at the Andrology Unit
(Department of Clinical Physiopathology, University of
Florence) where a fine-scale molecular characterisation of the
deletions using AZFc gene dosage and gene copy analysis was
carried out as described by Giachini et al.27 Y chromosome
haplogroup analysis was performed using the multiplexed
primers previously described4 adapted for SNaPshot single base
extension (Applied Biosystems, Foster City, California, USA) at
the Wellcome Trust Sanger Institute (Cambridge, UK) for153
subjects. The markers RPS4Y711, M145, M96, M89, M9 and
M45 were typed on all samples and M123, M78, V6, M35 and
M81 (haplogroup E, derived for M96), M201, M170, M52 and
12f2 (haplogroup F, derived for M89), M106, M61, M147, M214,
M27, M76 and M70 (haplogroup K, derived for M9) or M17,
M343, M369 and M18 (haplogroup P, derived for M45) on
appropriate subsamples, but data were combined into the major
haplogroups (E, F*(xK), K*(xP) and P) to provide numbers
suitable for most statistical analyses. Full data are available for
150 samples (supplementary table 1 online).
Gene dosage
To measure the copy number of these genes, quantitative
analysis of CDY1 and DAZ was performed using a modified
PCR-based method.11 We simultaneously amplified the AZFc
locus to be quantified (CDY1 or DAZ) and a homologous locus
outside the AZFc interval (CDY2 and DAZL, respectively) as an
internal standard with a known number of copies, using a single
primer pair in a PCR reaction with a maximum of 24 cycles (end
point of the exponential phase). The primers flank an insertion/
deletion difference of 3–5 bp, which allowed the products
amplified from the AZFc loci and the control loci to be separated
by polyacrylamide gel electrophoresis. One of the primers was
labelled at its 59 end with a fluorochrome (FAM). The reaction
was then mixed with formamide, denatured at 95uC for 5 min
and the differently sized loci separated on an automatic
sequencer (ABI Prism 310 Genetic Analyzer; PE Applied
Biosystems, Foster City, California, USA). Quantification was
performed by comparing the peak area of the AZFc locus with
its homolog.
Table 1 Frequency of each gr/gr rearrangement in the whole study population
Rearrangement type Total, n
Total, n
with semen
phenotypes
Normal sperm count, n Abnormal sperm count, n
Normo AT Total 1 Az Oz Total 2
gr/gr del 128 122 9 16 25 18 79 97
gr/gr del–b2/b4 dupl 23 22 — 4 4 7 11 18
gr/gr del–b2/b4 multiple dupl 3 3 — 1 1 — 2 2
gr/gr del–CDY1 ampl 4 1 — — — — 1 1
gr/gr del–DAZ ampl 2 1 — — — 1 — 1
Total (n) 160* 149{ 9 21 30 26 93 119
Ampl, amplification; AT, asthenozoospernic and/or teratozoospermic; Az, azoospermic; del, deletion; dupl, duplication; Normo,
normozoospermic; Oz, oligozoospermic; Total 1, normospermic plus pure AT; Total 2, AZ plus OZ.
*False deletions were excluded (n = 9).
{In 11 cases no information about the semen phenotype was given by the laboratories; subjects with known semen phenotypes
were divided into two major categories (normal or abnormal sperm) and further divided into subcategories.
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CDY1 vs CDY2 (primers: oMY953a/o1023)
There are two identical copies each of CDY1 and CDY2, which
share 98% nucleotide identity. We amplified CDY1 and CDY2
across a 3 bp indel difference in the coding region, to give
fragments of 134 bp for CDY1 and 137 bp for CDY2.
DAZ vs DAZL (primers: o1130/01313)
We coamplified a fragment of intron 10 from DAZ (214 bp) and
DAZL (217 bp). This intron is present in one copy per DAZ gene (in
the reference 46,XY man there were four copies of DAZ and two
copies of DAZL). Some samples showed a 40 bp insertion
polymorphism in the DAZL intron 10, resulting in an extra band at
260 bp, which could be heterozygous or, more rarely, homozygous.
Gene copy type
Qualitative analysis for CDY1 and DAZ, in order to determine
which copies of these genes have been removed by the gr/gr
deletion, was performed according to the method of Machev et
al.11 For DAZ, we chose the sequence family variant (SFV) at
STS sY587 in intron 10, which discriminates DAZ1/2 from
DAZ3/4. For CDY1, we used a C/A SFV situated 7750 bp 59 of
the CDY1 translation start codon (CDY7750), which distin-
guishes CDY1a from CDY1b. SFVs were scored by PCR followed
by restriction enzyme digestion (5 U for at least 4 hours): DAZ
sY587, DraI (DAZ1/2 cut); CDY1-7750, PvuII (CDY1b cut).
Digestion products were then analysed by electrophoresis at
100 V in 4% agarose gels containing ethidium bromide and
visualised under ultraviolet light. Primer pairs: sY587, o912/
o913; CDY1-7750, o1025/o1026.11
Statistical analysis
Median values between groups were compared using a non-
parametric Mann–Whitney U test or Student’s t test after
normalisation of the distribution by log transformation, as
shown by a one-sample Kolmogorov–Smirnov test; p = 0.023.
We also performed a regression analysis on the log-transformed
sperm counts to determine whether variation in sperm count
(the dependent variable) could be explained by any of the other
variables. Analyses were carried out using SPSS 14.0, except for
power calculations, which were performed using the website
http://www.danielsoper.com/statcalc/calc09.aspx.
RESULTS
Molecular analysis of the AZFc region
Definition of different gr/gr rearrangements
The molecular characterisation of samples sharing the absence
of the sY1291 was necessary in order to distinguish between
different gr/gr rearrangements that may not be found by the
STS analysis used by the participating laboratories and to
confirm the effective loss of genetic material—that is, to exclude
‘‘false’’ deletions (fig 2).
We defined the gene dosage of CDY1 and DAZ and the type
of missing DAZ (DAZ1/DAZ2/DAZ3/DAZ4) and CDY1
(CDY1a/CDY1b) copies. The gene dosage and gene copy types
are reported (fig 2) for each gr/gr rearrangement that could be
identified by this combined two-step method.
In nine subjects (one normospermic for all three parameters
and eight infertile with reduced sperm count) we found a
pattern compatible with ‘‘false’’ deletions, showing normal
DAZ and CDY1 gene dosage and the presence of both CDY1
copies (CDY1a/CDY1b) and all four DAZ copies (DAZ1/DAZ2/
DAZ3/DAZ4). False deletions using STS analysis can be due
either to polymorphisms/rearrangements at the annealing site
of the primers or to PCR artefacts. The nine samples were
reanalysed using simplex PCR with sY1291 at different
annealing temperatures, which confirmed that these were
undeleted in all cases, indicating that the failure of amplification
was due to suboptimum PCR conditions for those specific
samples (DNA quality may be responsible for such an
amplification failure) and the false deletion rate was 5.3%
(9/169). The nine samples originated from four different
laboratories and were excluded from further analyses.
In the remaining 160 subjects we found a heterogeneous
situation showing both ‘‘true’’ simple gr/gr deletions (n = 128),
gr/gr deletion followed by b2/b4 duplication (n = 23), gr/gr
deletion followed by multiple b2/b4 duplications (n = 3),
confirmed gr/gr deletion but a higher copy number of CDY
genes than the reference sequence (gr/gr deletion–CDY1
amplification) (n = 4) and confirmed gr/gr deletion but a higher
Figure 3 Comparison of the frequencies of the different gr/gr
rearrangement types in each participating country. False deletions and
gr/gr deletion–DAZ or CDY1 amplification were excluded from this
histogram. Figure 4 Comparison of the frequencies of the different gr/gr subtypes
in each participating country. False deletions and gr/gr deletion–DAZ or
CDY1 amplification were excluded from this histogram. Deletion
subtypes removed: (1) DAZ1/DAZ2+CDY1a; (2) DAZ3/DAZ4+CDY1a; (3)
DAZ1/DAZ2+CDY1b; (4) DAZ3/DAZ4+CDY1b.
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copy number of DAZ genes than the reference sequence (gr/gr
deletion–DAZ amplification) (n = 2) (fig 2, table 1).
Geographical distribution of gr/gr rearrangements
The most frequent gr/gr rearrangement type in all countries
was the simple gr/gr deletion, which ranged from 50%
(Hungary) to 95% (Italy). The number of Hungarian gr/gr
deletion carriers was low (n = 4) and 50% presented gr/gr
deletion–b2/b4 duplication. The frequency of gr/gr deletion–b2/b4
duplication varied between countries, being highest in Denmark
(24%) and lowest in Italy (4.5%) with a comparable number of
total subjects analysed from the two countries (21 and 22,
respectively). Interestingly, we found gr/gr deletion–b2/b4 multi-
ple duplication only in the German study population (8.8%) (fig 3).
Deletions with amplified DAZ or CDY copies are not included in
fig 3 because of their low number (n = 6). Three of four subjects
with gr/gr deletion –CDY1 amplification were French and one was
Australian. Both subjects with gr/gr deletion –DAZ amplification
were of Danish origin. Given the relatively low number of subjects
ineach group, differences inthe distribution of gr/gr rearrangement
types were not significant.
Definition of gr/gr deletion patterns (subtypes) based on the missing
copies of DAZ and CDY1 genes
Our restriction fragment length polymorphism (RFLP) method
is based on the use of an SFV at sY587 which differentiates
DAZ1 and DAZ2 from DAZ3 and DAZ4. In the majority of cases
(n = 154), we found deletion of either the DAZ1/DAZ2
(n = 106, 69%) or the DAZ3/DAZ4 (n = 48, 31%) gene pairs.
In six cases belonging either to the group of ‘‘true’’ gr/gr
deletions (n = 5) or to gr/gr deletion–b2/b4 duplications (n = 1)
the RFLP analysis identified a peculiar pattern characterised by
the combination of one DAZ gene from each gene pair. It can be
hypothesised that the recombination site was between the two
red amplicons (fig 3), removing either DAZ1 with DAZ3 or
DAZ2 with DAZ4. According to previous publications11 14 27 gr/
gr deletions may present either the removal of CDY1a or CDY1b
(fig 1). The position of the CDY1b copy on the AZFc reference
sequence implies that in those cases in which CDY1b is deleted,
an inversion polymorphism in the DAZ3/4 palindrome P1 may
have occurred. The alternative hypothesis of gene conversion of
CDY1a by CDY1b before deletion was considered highly
unlikely by Machev et al11 because CDY1b deletions were found
at high frequency in the gr/gr deleted subjects (48%) whereas
CDY1b gene conversion events were found only at low
frequency (,1%). In our study population (n = 159), we found
deletion of CDY1a in 107 (67%) subjects and of CDY1b in 52
(33%). In one case, there was insufficient DNA for RFLP
analysis of CDY1.
The combination of the different copies of the DAZ and CDY
genes gave four major gr/gr deletion patterns characterised by
the loss of: DAZ1/DAZ2+CDY1a (subtype 1), DAZ3/
DAZ4+CDY1a (subtype 2), DAZ1/DAZ2+CDY1b (subtype 3)
and DAZ3/DAZ4+CDY1b (subtype 4). The frequency of the
four subtypes in the whole study population (n = 153, exclud-
ing the six cases showing the combination of two DAZ gene for
each gene pair and the case with inconclusive CDY1-RFLP
results) was 65/153 (42.5%) for subtype 1; 37/153 (24.2%) for
subtype 2; 39/153 (25.5%) for subtype 3; 12/153 (7.8%) for
subtype 4.
Geographical distribution of gr/gr subtypes
There were significant differences between countries for
frequency of gr/gr subtypes 2 and 3, whereas subtypes 1 and
4 were more similarly distributed (fig 4). The highest frequency
of subtype 1 was found in Australia (50%), whereas the lowest
was in France (30%). Subtype 4 was more frequent in France,
Spain and Italy (13–20%) and less frequent in Australia,
Germany and Denmark (3.3–5%). This subtype was absent in
the four Hungarian gr/gr deletion carriers. Significant differ-
ences were found for the frequencies of subtype 2:Australia
with the lowest value (13%) versus Germany (36.7%), France
(50%) and Italy (41%) gave p values of 0.016, 0.008 and 0.01,
respectively. The difference was also significant between France
(the highest with 50%) and Spain (the second lowest, 13.3%)
Table 2 The frequency distribution of different subcategories defined on the basis of the missing DAZ and CDY1 copies
Normal sperm count, n (%) Abnormal sperm count, n (%)
Total 1+2,
n (%)gr/gr del
gr/gr del–
b2/b4 dupl
and MD Total 1 gr/gr del
gr/gr del–
b2/b4 dupl
and MD Total 2
Type of missing DAZ copies
DAZ1/2 14 (58.3) 4 (80) 18 (62.1) 62 (66.7) 15 (79) 77 (68.8) 95 (67.4)
DAZ3/4 10 (41.7) 1 (20) 11 (37.9) 31 (33.3) 4 (21) 35 (31.2) 46 (32.6)
Total 24 5 29 93 19 112 141*
Type of missing CDY1 copy
CDY1a 15 (60) 3 (60) 18 (60) 66 (68.8) 15 (75) 81 (69.8) 99 (67.8)
CDY1b 10 (40) 2 (40) 12 (40) 30 (31.2) 5 (25) 35 (30.2) 47 (32.2)
Total 25 5 30 96 20 116 146*
Deletion subtypes
1 8 (33.3) 2 (40) 10 (34.5) 37 (40.2) 11 (57.9) 48 (43.2) 58 (41.4)
2 6 (25) 1 (20) 7 (24.1) 25 (27.2) 4 (21.05) 29 (26.1) 36 (25.7)
3 6 (25) 2 (40) 8 (27.6) 23 (25) 4 (21.05) 27 (24.3) 35 (25)
4 4 (16.7) – 4 (13.8) 7 (7.6) – 7 (6.3) 11 (7.8)
Total 24 5 29 92 19 111 140*
Del, deletion; dupl, duplication; MD, multiple duplication; Total 1, n. gr/gr del plus n. gr/gr del–b2/b4 dupl and MD for subjects with normal sperm count; Total 2, n. gr/gr del plus n.
gr/gr del–b2/b4 dupl and MD for subjects with abnormal sperm count.
*Differences in total numbers (Total 1, Total 2 and Total 1+ 2) are due to six cases with unclassified DAZ deletions (one normal and five abnormal) and one case with an undefined
CDY1 copy deletion (one from the abnormal sperm count group).
The two cases with gr/gr del-CDY1 ampl and DAZ ampl were excluded from the table.
Deletion subtypes are: (1) DAZ1/DAZ2+CDY1a; (2) DAZ3/DAZ4+CDY1a; (3) DAZ1/DAZ2+CDY1b; (4) DAZ3/DAZ4+CDY1b.
The percentages are calculated from the totals in a vertical manner.
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(p = 0.05). Subtype 3 was completely absent from the French
samples and differences were significant when France (0%) was
compared with Australia (32.6%) and Denmark (40%),
(p = 0.036 and p = 0.022, respectively).
Genotype–phenotype correlations
To evaluate the effect of different gr/gr rearrangements and gr/
gr deletion subtypes on sperm production, we divided the study
population into two groups on the basis of the sperm count:
group 1 with abnormal sperm count (azoospermia or oligo-
zoospermia) and group 2 with normal sperm count (including
those subjects who presented either all three sperm parameters
above the normal range or only normal sperm concentration
independently of their fertility status). This subdivision meant
that in the group of subjects with ‘‘normal sperm count’’ we
also included 13 originating from the patient group with normal
sperm concentration but reduced sperm motility and/or
morphology (asthenozoospermia and/or teratozoospermia).
The mean (SD) of the sperm parameters in this combined
control group was: sperm concentration 59 (41.4)6106 sperma-
tazoa/ml; percentage progressive motility 37.2 (20)%; percen-
tage normal morphology 14.6 (10.7)%.
Rearrangements of gr/gr and semen phenotype categories
Given that different gr/gr rearrangements are associated with
different gene dosage, we tested the hypothesis that differences
in gene dosage might explain the heterogeneous semen
phenotype found in gr/gr deletion carriers. However, the
comparison of the two groups defined on the basis of sperm
count showed a similar distribution of the different gr/gr
rearrangements. The most prevalent rearrangement type in
both groups was the gr/gr deletion (81.5% in group 1, 83.3% in
group 2). Restoration of the original or higher gene dosage by
single or multiple duplications did not seem to influence the
phenotype as 17% of oligozoospermic/azoospermic subjects
carried deletion/duplication events and this rearrangement was
present at a similar frequency in the normozoospermic group
(17%). Data are reported in table 1. The nine ‘‘fully normos-
permic’’ controls who presented all three sperm parameters
above the normal range were all carriers of a simple gr/gr
deletion without duplications.
Rearrangements of gr/gr and mean sperm concentration
In subjects for whom sperm parameters were available
(n = 142), we compared the mean sperm concentration within
each rearrangement type. There was no significant difference
between subjects with half the AZFc gene dosage (gr/gr
deletion) compared with normal (deletion/duplication) and
higher copy number (deletion/multiple duplication): mean 16
(SD 32.2)6106/ml (n = 117) versus 9.3 (SD 13.7)6106/ml
(n = 24). The corresponding comparison was also performed
separately in subjects with abnormal sperm count (n = 111) and
in subjects with normal sperm concentrations (n = 30). The
comparison of gr/gr deleted and deleted/duplicated subjects in
the first group showed no difference, 2.9 (SD 3.8)6106/ml
(n = 92) versus 3.1 (SD 3.9)6106/ml (n = 19). Even after the
removal of azoospermic men (given that gr/gr deletions are
highly unlikely to be a definitive cause of azoospermia), the
mean values remained similar.
In contrast, the group of subjects with normal sperm
concentration showed nominally significant differences in gr/gr
deletion versus deletion/duplication and multiple duplication:
64.2 (SD 43.4)6106/ml (n = 25) versus 32.8 (SD 11.8)6106/ml
(n = 5), respectively (t test of logn spermatozoa/ml p = 0.042). As
all nine fully normospermic controls were carriers of gr/gr
deletions, such a comparison could not be performed in this
group. If we considered separately only the 16 subjects with
normal sperm concentration and were sent as controls, we
found a similar effect of duplications in this subgroup: 81.6 (SD
12.1)6106/ml (pure gr/gr deletions in 14 subjects) and 29.7 (SD
6.7)6106/ml (deletion—b2/b4 duplication and deletion–multiple
duplications in two subjects). This interesting observation could
have several explanations, including pure chance, as multiple tests
were performed and replication in an independent sample is
needed as the next step.
These data suggest that gene dosage differences are not a
critical determinant of sperm output in the group of oligos-
permic/azoospermic men (although the mean sperm concentra-
tion was lower when duplications occurred), whereas it may
reduce the spermatogenic potential in subjects with .20 million
spermatozoa/ml.
Deletion subtypes and semen phenotype categories
The most frequently deleted DAZ copy was DAZ1/2, whereas
the predominant missing CDY1 copy was CDY1a, in both
subjects with normal and abnormal sperm concentration
(table 2). We and others have previously hypothesised that
certain deletion subtypes based on the definition of the missing
DAZ (1/2 or 3/4) and CDY1 (a or b) copies (four possible
combinations) are enriched in patients and thus could be more
pathogenic than others. To test this hypothesis, we compared
the frequency of the four different gr/gr subtypes between
subjects with abnormal and normal sperm concentration. As
stated above, in six cases the RFLP analysis of the DAZ gene
showed a pattern which was different from the four classic
combinations and in one case the RFLP analysis of the CDY1
gene gave inconclusive result. These seven cases, together with
those presenting gr/gr deletion and amplified DAZ or CDY1
copy number, were excluded from the statistical analysis, so we
selected only those subjects who had either gr/gr deletion or gr/
gr deletion–b2/b4 duplication and multiple duplication (table 2).
In accordance with our previous data,14 the most frequent
subtype found in oligoazoospermic men was subtype 1, whereas
the least frequent was subtype 4. However, men with normal
sperm concentration also showed a similar frequency distribu-
tion for the four subtypes. It is nevertheless worth noting that,
in the present study, subtype 4 (the only gr/gr subtype found in
normospermic controls in the Italian sample14 28) was more
frequent in the normospermic control group (16.7%) than in the
oligospermic/azoospermic group (7.6%) (3.8% versus 6.3% if we
consider both gr/gr deletions and gr/gr deletion–b2/b4 duplica-
tion (single or multiple)). The phenotype associated with
subtype 4 therefore requires further investigation. The semen
phenotype of the six patients with the unusual DAZ deletion
pattern was heterogeneous, comprising azoospermia (n = 1),
cryptozoospermia (n = 2), severe oligoasthenoteratozoospermia
(n = 2) and asthenoteratozoospermia (n = 1). These data
indicate that this rare pattern is mainly associated with
abnormal spermatogenesis.
Deletion subtypes and mean sperm concentration
We compared the mean sperm concentration in subjects with
CDY1a deletion versus CDY1b deletion in the whole study
population and then separately in the group of subjects with
normal and abnormal sperm count. Data are reported in table 3,
in which we again excluded the six cases with unclassified DAZ
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copies and gr/gr deletions with DAZ and CDY1 copy amplifica-
tion. Therefore, for this analysis we selected only those subjects
who had either gr/gr deletion or gr/gr deletion–b2/b4 duplica-
tion or multiple duplications and with known sperm concen-
trations. Although in both groups with normal and abnormal
sperm count, the mean values of sperm concentration were
lower in cases of loss of DAZ1/DAZ2 or CDY1a copy loss, the
differences did not reach significance.
Y haplogroups and their relationship to AZFc rearrangements and
to the phenotypic expression of gr/gr deletions and deletions/
duplications
Y haplogroup analysis showed that haplogroups E, I, R1a and
R1b, here combined with related chromosomes into the broader
categories E, F*(xK), K*(xP) and P, made up most of the sample,
as expected for a predominantly western European mixed
sample (supplementary table 1). Haplogroup P was the most
frequent haplogroup in men with both normal and abnormal
sperm counts and the frequencies of the other haplogroups
followed the same order P.F*(xK).E.K*(xP) in the two groups
(table 4). Similarly, within each of the classes (normal sperm
concentration, abnormal sperm concentration or total), there
were no significant differences in mean sperm concentration
between the haplogroups (table 5). Duplications (including
multiple duplications) following deletions were more rare in
haplogroup P chromosomes than in other haplogroups and more
frequent in haplogroup E chromosomes, but these differences
were not significant (p = 0.08, p = 0.08 respectively; Fisher exact
test). These duplications were more frequent in Denmark and
Germany than in the other countries examined, but this
enrichment could not be accounted for by the haplogroup
distributions as haplogroup E is more common in south-eastern
European countries.24
Because removal of both CDY1b and sY1291 as a single event
implies the presence of an inversion polymorphism with respect
to the reference sequence, it was of interest to analyse the
haplogroup distribution in subjects with CDY1a versus CDY1b
deletion. We found that haplogroup P was significantly more
frequent when there was copy loss of CDY1a (56.7%) rather
than CDY1b (14.6%) p,0.001. On the other hand, 73% of
subjects with CDY1b copy loss have haplogroup F*(xP) or E
(56.3% and 16.7%), whereas in CDY1a loss carriers the
cumulative frequency of the same haplogroups was lower at
33% (haplogroup F*(xP) = 25% and haplogroup E = 7.7%).
Within haplogroup F*(xP), there was a highly significant
difference within haplogroup I which made up 81% of the
CDY1b loss chromosomes but only 19% of the CDY1a loss
chromosomes (p = 0.00001; data in supplementary table 1).
Finally, we used linear regression analysis on the same samples
to investigate whether the variation in sperm concentration of
oligospermic or normospermic men, considered as a continuous
variable, could be explained by any of the factors measured: gr/gr
versus deletion/duplication, CDY1 deletion, DAZ deletion or Y
haplogroup. None of these factors explained a significant
proportion of the variation in sperm count (all p.0.05).
DISCUSSION
This is the largest study to date to investigate the contribution
of Y-chromosome factors to the extensive and puzzling
phenotypic variation exhibited by gr/gr deletion carriers, which
ranges from normal spermatogenesis to azoospermia. The
factors examined included both the known AZFc structural
variants associated with this deletion (removal of various DAZ
and CDY1 gene copies, deletion followed by duplication) and
the more general Y chromosome background, measured as the
Y-SNP-defined haplogroup, which could reveal the influence of
factors located anywhere on the male-specific part of the
chromosome. We found that none of these factors accounted
for a significant proportion of the spermatogenic variation
associated with gr/gr deletions. We now consider whether any
aspects of our study design and execution could have led us to a
false negative conclusion, the power of the study to detect the
effects we were seeking and the implications of the conclusion
for biological understanding and clinical practice.
The study was designed to investigate a relatively homo-
geneous group of subjects with western European descent.
Genetic ancestry was confirmed by the presence of the expected
European Y haplogroups. All molecular characterisations were
Table 3 Sperm concentrations (6106/ml) of gr/gr deleted and gr/gr deleted–b2/b4 duplicated (single or multiple) men, classified on the basis of the
type of missing DAZ and CDY1 copies
Normal sperm count, mean (SD) (n) Abnormal sperm count, mean (SD) (n)
Totalgr/gr del
gr/gr del–
b2/b4
dupl and MD
gr/gr del
and gr/gr
del–b2/b4
dupl and MD gr/gr del
gr/gr del–
b2/b4 dupl
and MD
gr/gr del
and gr/gr
del–b2/b4
dupl and MD
Type of missing DAZ copies
DAZ1/2 62.2 (42.0) (14) 31.9 (13.4) (4) 55.5 (39.4) (18) 3.1 (3.9) (60) 3.3 (3.6) (14) 3.2 (3.8) (74) 13.4 (27.1) (92)
DAZ3/4 71.4 (46.7) (10) 36.5) (1) 68.2 (45.5) (11) 2.8 (3.5) (28) 2.9 (5.7) (4) 2.8 (3.7) (32) 19.6 (36.6) (43)
Total 66.0 (43.3) (24) 32.8 (11.8) (5) — 3.0 (3.8) (88) 3.2 (3.9) (18) — —
Type of missing CDY1 copy
CDY1a 52.7 (34.2) (15) 40.2 (8.6) (3) 50.6 (31.6) (18) 2.6 (3.4) (61) 3.4 (3.9) (14) 2.8 (3.5) (75) 12.0 (23.6) (93)
CDY1b 81.38 (51.4) (10) 21.7 (1.8) (2) 71.4 (52.0) (12) 3.5 (4.4) (30) 2.0 (4.1) (5) 3.3 (4.4) (35) 20.7 (39.5) (47)
Total 64.20 (43.3) (25) 32.8 (11.8) (5) — 2.9 (3.8) (91) 3.1 (3.9) (19) — —
Deletion subtypes
1 48.3 (28.2) (8) 42.0 (11.2) (2) 47.0 (25.3) (10) 2.6 (3.5) (35) 3.7 (3.3) (10) 2.8 (3.5) (45) 10.9 (20.3) (55)
2 64.2 (42.0) (6) 36.5) (1) 60.2 (39.7) (7) 3.1 (3.4) (22) 2.9 (5.7) (4) 3.1 (3.7) (26) 15.2 (29.5) (33)
3 80.8 (52.5) (6) 21.7 (1.8) (2) 66.0 (52.1) (8) 4.1 (4.5) (23) 2.5 (4.6) (4) 3.9 (4.5) (27) 18.1 (35.7) (35)
4 82.2 (57.8) (4) (0) 82.2 (57.8) (4) 1.5 (3.7) (7) (0) 1.5 (3.7) (7) 30.9 (51.7) (11)
Total 66.0 (43.3) (24) 32.8 (11.8) (5) — 3.0 (3.8) (87) 3.2 (3.9) (18) — —
Del, deletion; dupl, duplication; MD, multiple duplication
The means of sperm concentration in these gr/gr rearrangements, further divided on the basis of the deletion subtype, are also shown.
Deletion subtypes are: (1) DAZ1/DAZ2+CDY1a; (2) DAZ3/DAZ4+CDY1a; (3) DAZ1/DAZ2+CDY1b; (4) DAZ3/DAZ4+CDY1b.
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conducted in a single centre (eliminating ,5% false positives
from the original screen in the process), ensuring that uniform
standards of genotype calling were applied to the entire set of
samples. Our study was well-powered. For example, with a
sample size of 134 and the standard requirement for p = 0.05,
we would have 80% power to detect a variable that explained
>5.5% of the variation in sperm count. We therefore conclude
that Y-chromosomal factors do not explain any substantial
proportion of the variation in sperm phenotype of western
European gr/gr deletion carriers.
The presence of certain Y haplogroups with constitutive
deletions, both gr/gr and b2/b3, at high frequency in popula-
tions such as the Japanese and Finnish populations, respectively,
led to the hypothesis that these Y chromosomes might also
carry constitutive duplications that would counteract the
deleterious effects of the gene dosage reduction. According to
the hypothesis that gene dosage differences generally underlie
phenotypic variation, we would expect to have seen a higher
rate of del/dupl events in the normospermic group examined
here. Our results excluded this possibility; on the contrary, they
suggested that deletion followed by duplication may negatively
affect spermatogenic efficiency. Subjects with deletion/duplica-
tions showed lower sperm concentration in both normospermic
and infertile groups, although the finding reached significance
only in the normospermic group. A possible explanation could
be that deletion followed by duplications may indicate a higher
propensity to genomic instability which may not be restricted
to the AZFc region.
The definition of different DAZ and CDY1 copies in our
study has two implications. Several studies have indicated that
DAZ1/DAZ2 deletions are restricted to gr/gr carriers with
impaired sperm production14 18 21 and it was therefore proposed
that these two copies may be biologically more important than
the others. We found no significant phenotypic difference
according to the deletion of different DAZ and CDY1 gene
copies, implying that these genes are either irrelevant to sperm
output (which is unlikely to be true for both) or functionally
equivalent. The second implication is that whereas the
definition of the Y haplogroups provides information about
the Y chromosome structure as a whole, the removal of
different DAZ and CDY1 copies may reflect a particular AZFc
structure on which gr/gr deletion took place, which can be
present in several lineages, albeit at different frequencies. Our
data indicate that special rearrangements such as inversion
polymorphism (which should precede, for example, the
removal of CDY1b copy in case of sY1291 loss) are probably
not relevant for the phenotypic expression of deletions. On the
other hand we found significant differences in the haplogroup
distribution between carriers with the loss of CDY1a and
CDY1b, indicating that some structural rearrangements in the
AZFc region may be associated with particular haplogroups (eg,
CDY1b deletion in haplogroup I).
Table 4 Comparison of the frequency of gr/gr deletion and gr/gr deletion–b2/b4 duplication (single or
multiple) in men with normal and abnormal sperm count, divided on the basis of their Y haplogroup
Normal sperm count, n (%) Abnormal sperm count, n (%)
Total
1+ 2
gr/gr del
gr/gr del–
b2/b4
dupl and
MD Total 1 gr/gr del
Gr/gr del–
b2/b4
dupl and
MD Total 2
Y haplogroup
F*(xK) 6 (25) 1 (20) 7 (24.1) 34 (37.4) 8 (42.1) 42 (38.2) 49 (35.2)
P 14 (58.3) 2 (40) 16 (55.2) 42 (46.2) 6 (31.6) 48 (43.6) 64 (46)
K*(xP) 2 (8.3) 1 (20) 3 (10.3) 7 (7.7) 1 (5.3) 8 (7.3) 11 (7.9)
E 2 (8.3) 1 (20) 3 (10.3) 8 (8.8) 4 (21.1) 12 (10.9) 15 (10.8)
Total 24 5 29 91 19 110 139
Del, deletion; dupl, duplication; MD, multiple duplication; Total 1, n. gr/gr del plus n. gr/gr del–b2/b4 dupl and MD for subjects with
normal sperm count; Total 2 = number of gr/gr del plus number of gr/gr del–b2/b4 dupl and MD for subjects with abnormal sperm
count
Table 5 Sperm concentration (6106/ml) of gr/gr deleted and gr/gr deleted–b2/b4 duplicated (single or
multiple) men, classified on the basis of their Y haplogroup
Normal sperm count, mean (SD) (n) Abnormal sperm count, mean (SD) (n)
Total 1+
Total 2gr/gr del
gr/gr del–
b2/b4
dupl and
MD Total 1 gr/gr del
gr/gr del–
b2/b4
dupl and
MD Total 2
Y haplogroup
F*(xK) 65.2 (49.1)
(6)
23.0
(1)
59.2 (47.6)
(7)
4.3 (4.7)
(34)
3.7 (4.5)
(8)
4.2 (4.6)
(42)
12.1 (26.1)
(49)
P 45.8 (27.6)
(14)
43.2 (9.5)
(2)
45.5 (25.8)
(16)
2.3 (3.0)
(40)
2.6 (3.6)
(5)
2.3 (3.0)
(45)
13.7 (23.2)
(61)
K*(xP) 94.0 (55.1)
(2)
20.5
(1)
69.5 (57.6)
(3)
1.8 (3.0)
(5)
0.0
(1)
1.5 (2.8)
(6)
24.2 (44.6)
(9)
E 126.5 (37.5)
(2)
34.1
(1)
95.7 (59.6)
(3)
1.1 (1.9)
(8)
3.8 (4.2)
(4)
2.0 (3.0)
(12)
20.7 (44.9)
(15)
Total 61.4 (42.0)
(24)
32.8 (11.8)
(5)
— 3.0 (3.8)
(87)
3.2 (3.9)
(18)
— —
Del, deletion; dupl, duplication; MD, multiple duplication.
Data are mean (SD) (n) with n shown on the lower line; in the cases where n = 1, there is no SD.
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This study has important implications also for clinical
practice. Although we did not find an evident correlation
between Y haplogroups and the phenotypic expression of gr/gr
rearrangements, it is worth noting that geographical differences
were found. It is therefore likely that a genetic factor with a
relatively mild phenotypic effect may be more penetrant in
certain populations than in others and this may contribute to
bias in admixed populations. Although we were unable to
distinguish between ‘‘pathogenic’’ and ‘‘neutral’’ deletions,
gr/gr deletions as a group are considered a significant risk factor
for spermatogenic failure.28 29 This conclusion might encourage
some laboratories to screen for this genetic anomaly before
using assisted reproductive techniques, as this genetic risk factor
will be obligatorily transmitted to the male offspring. In this
regard it is important to note that in the populations examined
here, the false deletion rate of 5.3% in the sY1291-based test as
it is routinely used is a cause for concern. Care should be taken
to distinguish amplification failures from true deletions.
Suspected deletions should be verified through the use of
different PCR conditions or by redesigning the assay into a
multiplex format with internal positive control fragments or
performing a gene dosage analysis as used in this study. Second,
there is at present no justification for subtyping of gr/gr
deletions to inform counselling of carriers of European decent.
We emphasise, however, that this last conclusion is only
relevant to carriers with ancestry restricted to western Europe;
in other areas of the world the matter remains open, and in a
population with mixed western European/Japanese ancestry,
identification of the low-risk haplogroup D gr/gr deletion
chromosomes would be positively indicated.
In conclusion, our study has provided evidence that neither
the definition of Y haplogroups nor the definition of gr/gr
subtypes on the basis of the dosage or the missing DAZ and
CDY copies are able to provide an explanation for the
heterogeneous phenotype found in gr/gr deletion carriers.
However, our study provides evidence for significant geogra-
phical differences in the distribution of deletion subtypes which
may affect the outcome of case control association studies in
different geographical areas.
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